Vor Biopharma Appoints Dr. Bill Lundberg to Its Board of Directors
CAMBRIDGE--(BUSINESS WIRE)--Jul 31, 2019-- Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of hematological cancers, today announced the appointment of Bill Lundberg, MD, to its Board of Directors …